Source: Annual Congress 2006 - Smoking cessation: why and how
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. V. Shchukina, V. I. Trofimov, O. I. Karpov (Saint Petersburg, Russian Federation). The tobacco-smoking influence on the community-acquired pneumonia course. Eur Respir J 2006; 28: Suppl. 50, 1446

Member's Comments

No comment yet.

Related content which might interest you: Peculiarities of community-acquired pneumonia in tobacco-smoking patients Source: Annual Congress 2009 - Tobacco: from smoke to disease Year: 2009 The influence of smoking habit in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 149s Year: 2003 Mixed community-acquired pneumonia in hospitalised patients Source: Eur Respir J 2006; 27: 795-800 Year: 2006 The tobacco smoking prolongation and intensity influence on the community-acquired pneumonia course Source: Eur Respir J 2004; 24: Suppl. 48, 153s Year: 2004 The main risk factors of the community-acquired pneumonia delayed course Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005 The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Epidemiology of community-acquired pneumonia and nosocomial pneumonia Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Impact of aspiration pneumonia in community-acquired pneumonia and healthcare-associated pneumonia Source: Annual Congress 2012 - CT findings: educational posters Year: 2012 Nosocomial pneumonia: influence of smoking on the course of disease Source: Annual Congress 2007 - Infectious lung and pleural diseases Year: 2007 COPD: what is the frequency and impact of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2010; 36: 128-134 Year: 2010 Corticosteroids and community-acquired pneumonia Source: Annual Congress 2007 - Corticosteroids and respiratory failure Year: 2007 MRSA as a cause of community-acquired pneumonia Source: Eur Respir J 2009; 34: 1013-1014 Year: 2009 Ethyology of community-acquired pneumonia in servicemen at the age of 18–21 Source: Eur Respir J 2006; 28: Suppl. 50, 736s Year: 2006 Effect of corticoids on the clinical course and outcome of severe community-acquired pneumonia Source: Annual Congress 2004 - SARS and other lower respiratory tract infections Year: 2004 Preventing community-acquired pneumonia Source: International Congress 2019 – Respiratory infections: prevention is better than cure Year: 2019 Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia Source: Annual Congress 2007 - Infections year in review Year: 2007 Community-acquired pneumonia: impact of COPD Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 Factors associated with unknown aetiology in patients with community-acquired pneumonia Source: Eur Respir J 2002; 20: 1254-1262 Year: 2002 Community-acquired pneumonia in younger patients is an entity on its own Source: Eur Respir J 2012; 39: 1156-1161 Year: 2012